|
JP2020156481A
|
|
Gene defects and mutant alk kinase in human solid tumors
|
|
WO2019032775A1
|
|
Apparatus for supporting and carrying container with respect to optical reader
|
|
JP2017163992A
|
|
Gene defect and mutant alk kinase in human solid tumor
|
|
US2017205422A1
|
|
Mass spectrometry analysis of mutant polypeptides in biological samples
|
|
US2016137725A1
|
|
Methylation and acetylation sites
|
|
WO2016044736A1
|
|
Altered antibodies and methods of making the same
|
|
US2015259405A1
|
|
Production of motif-specific and context-independent antibodies using peptide libraries as antigens
|
|
US2015232540A1
|
|
Analysis of ubiquitnated polypeptides
|
|
AU2014265106A1
|
|
Compositions and methods for detecting EGFR mutations in cancer
|
|
JP2014168466A
|
|
Gene deletion and mutant alk kinase in human solid tumor
|
|
US2014134640A1
|
|
Gene Defects And Mutant ALK Kinase In Human Solid Tumors
|
|
WO2013165972A2
|
|
Anti-hepatitis b virus antibodies and use thereof
|
|
WO2013165982A2
|
|
Anti-human cytomegalvirus antibodies and use thereof
|
|
US2015056193A1
|
|
Egfr and ros1 kinase in cancer
|
|
WO2013016653A1
|
|
Multi component detection
|
|
CN106148525A
|
|
ROS kinases in pulmonary carcinoma
|
|
KR20190006083A
|
|
Methods and reagents for creating monoclonal antibodies
|
|
AU2012201154A1
|
|
Gene defects and mutant ALK kinase in human solid tumors
|
|
WO2012075318A2
|
|
Fn1 and alk gene translocations in cancer and alk kinase expression in ovarian cancer
|
|
WO2012061732A1
|
|
Motif-specific and context-independent antibodies to a cleaved caspase motif or a sumoylated lysine-containing motif
|
